title: No clear link between VKORC1 genetic polymorphism and the risk of venous thrombosis or peripheral arterial disease.
authors.forename: David M
authors.initials: DM
authors.lastname: Smadja
authors.forename: Marie-Anne
authors.initials: MA
authors.lastname: Loriot
authors.forename: Lucia A
authors.initials: LA
authors.lastname: Hindorff
authors.forename: Lucille
authors.initials: L
authors.lastname: Mellottee
authors.forename: Pascale
authors.initials: P
authors.lastname: Gaussem
authors.forename: Joseph
authors.initials: J
authors.lastname: Emmerich
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D016022:Case-Control Studies; D004351:Drug Resistance; D005260:Female; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D006239:Haplotypes; D006801:Humans; D008297:Male; D006899:Mixed Function Oxygenases / Q000235:genetics*; D016017:Odds Ratio; D016491:Peripheral Vascular Diseases / Q000188:drug therapy / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide; D011401:Promoter Regions, Genetic; D018570:Risk Assessment; D012307:Risk Factors; D054556:Venous Thromboembolism / Q000188:drug therapy / Q000235:genetics*; D020246:Venous Thrombosis / Q000188:drug therapy / Q000235:genetics*; D064417:Vitamin K Epoxide Reductases; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D014859:Warfarin; D006899:Mixed Function Oxygenases; C578523:VKORC1 protein, human; D064417:Vitamin K Epoxide Reductases